These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 8070295)
1. [The observation of therapy of anemia in chronic renal failure with recombinant human erythropoietin]. Jiang Y; Liu P; Wang EJ Zhonghua Nei Ke Za Zhi; 1994 Feb; 33(2):80-2. PubMed ID: 8070295 [TBL] [Abstract][Full Text] [Related]
2. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis]. Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875 [TBL] [Abstract][Full Text] [Related]
3. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period. Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241 [TBL] [Abstract][Full Text] [Related]
4. Guidelines for recombinant human erythropoietin therapy. Eschbach JW; Adamson JW Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):2-8. PubMed ID: 2667349 [TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum. Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507 [TBL] [Abstract][Full Text] [Related]
6. [The correction of anemia with a high requirement for transfusion in patients on maintenance hemodialysis by conventional and reduced doses of recombinant human erythropoietin]. Sivak L; Scuteri RM; Cavalli NH; Gotlieb D; López Blanco OA Medicina (B Aires); 1992; 52(6):516-22. PubMed ID: 1340900 [TBL] [Abstract][Full Text] [Related]
7. [The effect of low doses of recombinant human erythropoietin on renal anemia in predialysis patients with chronic renal failure]. Zheng FL; Bi ZQ; Li RS Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):440-3. PubMed ID: 8275819 [TBL] [Abstract][Full Text] [Related]
8. Monitoring considerations in recombinant human erythropoietin therapy. Ogden DA Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080 [TBL] [Abstract][Full Text] [Related]
9. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration]. Zehnder C; Blumberg A Schweiz Med Wochenschr; 1990 Feb; 120(7):217-20. PubMed ID: 2309110 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r-HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics. Cotes PM; Pippard MJ; Reid CD; Winearls CG; Oliver DO; Royston JP Q J Med; 1989 Feb; 70(262):113-37. PubMed ID: 2594953 [TBL] [Abstract][Full Text] [Related]
11. Who should receive recombinant human erythropoietin? Van Stone JC Semin Nephrol; 1989 Mar; 9(1 Suppl 2):3-7. PubMed ID: 2669084 [TBL] [Abstract][Full Text] [Related]
12. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency]. Dimković N Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group. Kulzer P; Schaefer RM; Krahn R; Schaefer L; Heidland A Int J Artif Organs; 1994 Apr; 17(4):195-202. PubMed ID: 8070941 [TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients. Mohini R Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516 [TBL] [Abstract][Full Text] [Related]
15. [Clinical studies of recombinant human erythropoietin in patients on long-term dialysis]. Ji SM; Li LS; Ji DX Zhonghua Nei Ke Za Zhi; 1993 Feb; 32(2):100-2. PubMed ID: 8404323 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of anemia in patients with renal failure using erythropoietin obtained by genetic recombination]. Wiecek A; Kokot F; Grzeszczak W; Klin M Pol Tyg Lek; 1990 Sep 17-24; 45(38-39):782-6. PubMed ID: 2095546 [TBL] [Abstract][Full Text] [Related]
17. Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients. Abraham PA; Opsahl JA; Rachael KM; Asinger R; Halstenson CE Am J Nephrol; 1990; 10(2):128-36. PubMed ID: 2349956 [TBL] [Abstract][Full Text] [Related]
18. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study. Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC; Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340 [TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis]. Graf H; Mayer G; Cada EM; Thum J; Stummvoll HK Wien Klin Wochenschr; 1987 Dec; 99(24):855-9. PubMed ID: 3439185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]